Impax Asset Management Group’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
Impax Asset Management Group's RGEN Position: Q3 2026 in Review
Impax Asset Management Group reduced its Repligen (RGEN) stake by 25% in Q3 2026, selling an estimated $16.3M and leaving 296,060 shares worth $56.9M. The position accounts for 0.44% of the portfolio, ranked #55.
Impax Asset Management Group first reported a position in RGEN in Q1 2020 and has held it in 27 quarters since. The position peaked at $214M in Q4 2021. 523 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.
- Impax Asset Management Group held 296,060 shares of Repligen worth $56.9M as of Q3 2026.
- Impax Asset Management Group sold 100,453 Repligen shares in Q3 2026, an estimated $16.3M.
- Repligen made up 0.44% of Impax Asset Management Group's portfolio in Q3 2026, its #55 holding.
- Impax Asset Management Group first reported a position in Repligen in Q1 2020 and has held it in 27 quarters since.
- Impax Asset Management Group's Repligen position peaked at $214M in Q4 2021.
- 523 funds tracked by Wall St. Rank held Repligen as of Q3 2026.
Based on Impax Asset Management Group's 13F filing for Q3 2026, filed 10 Nov 2026.